NCT03619031

Brief Summary

The purpose of this study is to compare in patients with type 1 diabetes the postprandial glucose response to the consumption of three types of pizza, obtained with different leavening techniques. The intervention will be preceded by a one-week run-in period during which participants will undergo continuous glucose monitoring (CGM) to optimize basal infusion rate and insulin-to-glycemic load ratio. According to a randomized crossover design, the participants will consume at home at dinner-time in three different days over a 3-week period in random order: 1) a long-leavened pizza, composed of sourdough and a flour mix; 2) a short-leavened pizza, composed of sourdough and a flour mix; 3) a traditional pizza, composed of brewer's yeast and refined wheat flour, used as control. Over the three experimental weeks, participants will undergo CGM, wearing their sensors 7 days/week. The results of this study will allow optimizing insulin therapy based on the different characteristics of pizza in patients with type 1 diabetes mellitus treated with insulin pump. This will improve glycemic control and quality of life of these patients and reduce their risk of developing chronic diabetes complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 7, 2018

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2018

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2018

Completed
Last Updated

July 30, 2019

Status Verified

July 1, 2019

Enrollment Period

4 months

First QC Date

August 2, 2018

Last Update Submit

July 29, 2019

Conditions

Keywords

type 1 diabetespostprandial glycemiapizza leavening

Outcome Measures

Primary Outcomes (2)

  • Postprandial glucose response (AUC)

    Area under the curve

    2 hours

  • Postprandial glucose response (AUC)

    Area under the curve

    8 hours

Secondary Outcomes (2)

  • Blood glucose peak

    8 hours

  • Time to blood glucose peak

    8 hours

Study Arms (3)

LONG LEAVENING

EXPERIMENTAL

Acute test meal

Other: LONG LEAVENING

SHORT LEAVENING

EXPERIMENTAL

Acute test meal

Other: SHORT LEAVENING

TRADITIONAL

ACTIVE COMPARATOR

Acute test meal

Other: TRADITIONAL

Interventions

a long-leavened (60 h) pizza composed of sourdough and a flour mix.

LONG LEAVENING

a short-leavened (5 h) pizza composed of sourdough and a flour mix.

SHORT LEAVENING

a short-leavened (5 h) pizza composed of brewer's yeast and 00 flour.

TRADITIONAL

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Treatment with continuous subcutaneous insulin infusion for at least 6 months
  • HbA1c less than 8.0% (64 mmol/mol)

You may not qualify if:

  • Pregnancy
  • Celiac disease
  • Serious microvascular and macrovascular diabetes complications including autonomic neuropathy possibly influencing gastric emptying
  • Any other chronic or acute disease apart diabetes seriously affecting health status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Medicine and Surgery

Naples, 80131, Italy

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 2, 2018

First Posted

August 7, 2018

Study Start

May 3, 2018

Primary Completion

August 30, 2018

Study Completion

September 15, 2018

Last Updated

July 30, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations